PMID: 6985998Feb 15, 1980Paper

A randomized, controlled trial of aspirin in persons recovered from myocardial infarction

JAMA : the Journal of the American Medical Association

Abstract

The Aspirin Myocardial Infarction Study (AMIS) was a National Heart, Lung and Blood Institute-sponsored, multicenter, randomized, double-blind, and placebo-controlled trial designed to test whether the regular administration of aspirin to men and women who had experienced at least one documented myocardial infarction (MI) would result in a significant reduction in total mortality over a three-year period. Cause-specific mortality, nonfatal events, and side effects were also evaluated. Over a 13-month period, 4,524 persons between the ages of 30 and 69 years were randomized to either 1 g of aspirin per day (2,267 persons) or placebo (2,257 persons). High levels of patient compliance to study protocol were indicated by various measures. Total mortality during the entire follow-up period was 10.8% in the aspirin group and 9.7% in the placebo group. Three-year total mortality was 9.6% in the aspirin group and 8.8% in the placebo group. The percentage of definite nonfatal MI was 8.1% in the placebo group and 6.3% in the aspirin group. Coronary incidence (coronary heart disease mortality or definite nonfatal MI) was 14.1% in the aspirin group and 14.8% in the placebo group. Symptoms suggestive of peptic ulcer, gastritis, or erosion o...Continue Reading

Associated Clinical Trials

Citations

Jul 1, 1991·European Journal of Epidemiology·A HofmanF A van den Ouweland
Dec 1, 1983·Controlled Clinical Trials·P L Canner
Dec 1, 1983·Controlled Clinical Trials·P L Canner, C R Klimt
Dec 1, 1983·Controlled Clinical Trials·A HainlineA Mather
Aug 1, 1993·Controlled Clinical Trials·M D ThornquistM Cherniack
Jun 1, 1989·Controlled Clinical Trials·S N Goodman
Dec 1, 1989·Controlled Clinical Trials·M L Beach, P Meier
Dec 1, 1987·Controlled Clinical Trials·J A Schoenberger
Jun 1, 1985·Controlled Clinical Trials·R L BellC Payton-Ross
Jun 1, 1985·Controlled Clinical Trials·M E MattsonR McArdle
Sep 1, 1982·Controlled Clinical Trials·W T Friedewald, J A Schoenberger
Sep 1, 1982·Controlled Clinical Trials·T C Chalmers
Mar 1, 1982·Controlled Clinical Trials·R L Bell, E O Smith
Dec 25, 2009·Circulation. Cardiovascular Quality and Outcomes·Jeffrey S BergerSylvia Wassertheil-Smoller
Jul 21, 1998·European Journal of Pharmacology·Y YoshidaM Osame
Feb 24, 2006·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Deepak ThataiPatrick M Pullicino
Oct 1, 1990·Controlled Clinical Trials·E Brittain, J Wittes
Dec 1, 1989·Controlled Clinical Trials·C R Klimt
Oct 17, 2006·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Worawit LouthrenooWaraporn Sukitawut
Oct 3, 2001·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·J A Oviedo, M M Wolfe
Sep 1, 1995·The Journal of Pharmacy and Pharmacology·K YokotaM Oda
Dec 24, 2010·Current Opinion in Rheumatology·Eswar Krishnan, Jeremy Sokolove
Apr 7, 2007·Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing·John G F ClelandMansour Nasir
Aug 12, 1999·Journal of Cardiovascular Pharmacology·J G Cleland, J McGowan
Aug 23, 1980·Lancet·W D Rees, L A Turnberg
Jul 1, 1983·Annals of Neurology·J P Whisnant
Aug 10, 2001·Current Opinion in Nephrology and Hypertension·J G ClelandT Houghton
Nov 16, 2006·Expert Opinion on Therapeutic Targets·Catriona M TurnbullIan L Megson
Jan 1, 1981·Current Medical Research and Opinion·J A Tulloch, T C Marr
Aug 1, 1990·The American Journal of the Medical Sciences·M Feldman
Jan 1, 1995·Arthritis and Rheumatism·D R LichtensteinM M Wolfe
Dec 29, 2010·Contemporary Clinical Trials·Jyotsna KasturiMariusz Lubomirski
Feb 11, 2005·Journal of Thrombosis and Haemostasis : JTH·C L Campbell, S R Steinhubl
Jun 29, 2004·Journal of Thrombosis and Haemostasis : JTH·H K Breddin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrophic Gastritis

Atrophic Gastritis is a process where gastric glandular cells are lost and replaced with firbous tissues, as a result of chronic inflammation. Learn more about Atrophic Gastritis here.